[PDF][PDF] TCR-NK cells: a novel source for adoptive immunotherapy of cancer
ZS Karahan, M Aras, T Sütlü - Turkish Journal of Hematology, 2023 - jag.journalagent.com
Antigen-specific retargeting of cytotoxic lymphocytes against tumorassociated antigens has
thus far remained largely dependent on chimeric antigen receptors (CARs) that can be …
thus far remained largely dependent on chimeric antigen receptors (CARs) that can be …
Treatment of multiple sclerosis with T–cell receptor peptides: Results of a double–blind pilot trial
AA Vandenbark, YK Chou, R Whitham, M Mass… - Nature medicine, 1996 - nature.com
AT–cell receptor (TCR) peptide vaccine from the Vβ5. 2 sequence expressed in multiple
sclerosis (MS) plaques and on myelin basic protein (MBP)–specific T cells boosted peptide …
sclerosis (MS) plaques and on myelin basic protein (MBP)–specific T cells boosted peptide …
Targeting non-receptor tyrosine kinases using small molecule inhibitors: an overview of recent advances
M Hojjat-Farsangi - Journal of drug targeting, 2016 - Taylor & Francis
Protein tyrosine kinases are enzymes that catalyze the transfer of phosphate groups from
ATP to tyrosine residues on other proteins as substrate. Phosphorylation at tyrosine residues …
ATP to tyrosine residues on other proteins as substrate. Phosphorylation at tyrosine residues …
T-lymphocytes that accumulate in the lung in sarcoidosis have evidence of recent stimulation of the T-cell antigen receptor
RM Du Bois, M Kirby, B Balbi, C Saltini… - Am Rev Respir …, 1992 - atsjournals.org
Sarcoidosis, a granulomatous disease of unknown etiology, is characterized at sites of
disease such as the lung by the accumulation of large numbers of T-Iymphocytes …
disease such as the lung by the accumulation of large numbers of T-Iymphocytes …
T cell receptor peptides as therapeutics for immune-related disease
AA Vandenbark - US Patent 5,614,192, 1997 - Google Patents
KISWVXRQTGLFGD-UHFFFAOYSA-N 2-[[2-[[6-amino-2-[[2-[[2-[[5-amino-2-[[2-[[1-[2-[[6-
amino-2-[(2, 5-diamino-5-oxopentanoyl) amino] hexanoyl] amino]-5 …
amino-2-[(2, 5-diamino-5-oxopentanoyl) amino] hexanoyl] amino]-5 …
TCR peptide therapy in autoimmune diseases
AA Vandenbark, G Hashim, H Offner - International reviews of …, 1993 - Taylor & Francis
T cell-mediated autoimmunity may be viewed as the selection and expansion of" self"
reactive clones that are not deleted during thymic maturation [l]. The thymic negative …
reactive clones that are not deleted during thymic maturation [l]. The thymic negative …
重型乙型肝炎血清β2-微球蛋白检测及临床意义
陈瑞烈, 李吉婷, 刘敏, 方少鹏 - 临床肝胆病杂志, 2002 - lcgdbzz.com
探讨重型乙型肝炎血清β2 微球蛋白(β2-MG) 水平与肝组织损伤程度之间的关系.
应用放射免疫法(RIA) 检测5 3 例重型乙型肝炎, 4 4 例急性乙型肝炎患者及31 例正常人血清β2 …
应用放射免疫法(RIA) 检测5 3 例重型乙型肝炎, 4 4 例急性乙型肝炎患者及31 例正常人血清β2 …
Epitope specificity and V gene expression of cerebrospinal fluid T cells specific for intact versus cryptic epitopes of myelin basic protein
K Satyanarayana, YK Chou, D Bourdette… - Journal of …, 1993 - Elsevier
Recent evidence supports the possible involvement of myelin basic protein (BP) as one of
the target autoantigens in multiple sclerosis (MS), including elevated frequencies of MS …
the target autoantigens in multiple sclerosis (MS), including elevated frequencies of MS …
Human autoimmune thyroid disease A mechanistic update
G O'Connor, TF Davies - Trends in Endocrinology & Metabolism, 1990 - cell.com
Background Humoral abnormalities have been identified in autoimmune thyroid disease
(AITD) since the 1950s (Adams and Purves 1956; Roitt et al. 1956; Rose and Witebsky …
(AITD) since the 1950s (Adams and Purves 1956; Roitt et al. 1956; Rose and Witebsky …
Immunity to T cell receptor peptides: theory and applications
H Offner, GA Hashim, AA Vandenbark - Regulatory peptides, 1994 - Elsevier
Immunity to T cell receptor peptides: theory and applications - ScienceDirect Skip to main
contentSkip to article Elsevier logo Journals & Books Search RegisterSign in View PDF …
contentSkip to article Elsevier logo Journals & Books Search RegisterSign in View PDF …